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Neuropepetide Y (NPY) is best known for its powerful
stimulation of food intake and its effects on reducing
energy expenditure. However, the pathways involved
and the regulatory mechanisms behind this are not
well understood. Here we demonstrate that NPY
derived from the arcuate nucleus (Arc) is critical
for the control of sympathetic outflow and brown
adipose tissue (BAT) function. Mechanistically, a
key change induced byArcNPY signaling is amarked
Y1 receptor-mediated reduction in tyrosine hydroxy-
lase (TH) expression in the hypothalamic paraven-
tricular nucleus (PVN), which is also associated with
a reduction in TH expression in the locus coeruleus
(LC) and other regions in the brainstem. Consistent
with this, Arc NPY signaling decreased sympatheti-
cally innervated BAT thermogenesis, involving the
downregulation of uncoupling protein 1 (UCP1) ex-
pression in BAT. Taken together, these data reveal
a powerful Arc-NPY-regulated neuronal circuit that
controls BAT thermogenesis and sympathetic output
via TH neurons.
INTRODUCTION
Obesity occurs when there is a significant imbalance between
energy intake and energy expenditure (Rosen and Spiegelman,
2006). While energy intake is almost entirely determined by
food intake, energy expenditure is composed of several compo-
nents, including basal metabolism, physical activity, and ther-
mogenesis (Rosen and Spiegelman, 2006). Reduced adaptive
thermogenesis has been reported to be responsible for reduced
energy expenditure during energy deficit, as in weight loss
programs (Major et al., 2007). In recent years, more focused236 Cell Metabolism 17, 236–248, February 5, 2013 ª2013 Elsevier Inresearch into the regulation of thermogenesis, particularly brown
adipose tissue (BAT) thermogenesis, has indicated that BAT is
under tight control by the central nervous system (CNS) (Whittle
et al., 2011), of which the hypothalamus, and in particular the
arcuate nucleus (Arc), has attracted special attention.
The Arc contains two major populations of neurons that
are known to regulate energy balance: orexigenic neuropeptide
Y (NPY)/agouti-related peptide (AGRP)-containing neurons,
and anorexigenic proopiomelanocortin (POMC)/cocaine and
amphetamine-regulated transcript (CART)-containing neurons
(Lin et al., 2004) (Hahn et al., 1998). Activation of NPY/AGRP
neurons leads to the release of NPY and AGRP, which strongly
stimulate appetite and, when chronically elevated, lead to the
development of obesity (Ellacott and Cone, 2004). This occurs
via signaling of NPY on Y receptors, notably Y1 and Y5 receptors
(Nguyen et al., 2012), as well as via the ability of AGRP to antag-
onize melanocortin 3/4 (MC3/4) receptors (Ellacott and Cone,
2004). Consistent with an important role of NPY in the regulation
of energy homeostasis, chronic intracerebroventricular (i.c.v.) or
hypothalamus-specific administration of NPY to rodents leads to
hyperphagia, accompanied by accelerated bodyweight gain, hy-
perleptinemia, hypercorticosteronemia, hyperinsulinemia, and
increased adiposity (Sainsbury et al., 1997a; Zarjevski et al.,
1993). More importantly, all of these neuroendocrine and meta-
bolic effects of central NPY administration, notably increased
adiposity, persist even when NPY-induced hyperphagia is pre-
vented by pair feeding (Sainsbury et al., 1997b; Zarjevski et al.,
1993). This indicates that hyperphagia is not the only mechanism
by which central NPY increases adiposity and demonstrates that
hypothalamic NPY must also alter other processes, such as
energy expenditure, that contribute to the increased adiposity.
In addition, elevated NPY-ergic tone and decreased adaptive
thermogenesis during energy restriction and weight loss inter-
vention suggest a possible relationship between Arc NPY
signaling and adaptive thermogenesis (Major et al., 2007).
Despite the number of studies documenting the effects
of central NPY administration on energy homeostasis, thec.
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central and peripheral signaling pathways, are yet to be eluci-
dated. One mechanism by which Arc NPY may decrease energy
expenditure is through interaction with the sympathetic nervous
system (SNS). Interestingly, increased hypothalamic NPY ex-
pression has been shown in animal models of obesity (Lin
et al., 2000), and elevated circulating NPY levels have been
found in obese women (Baranowska et al., 2005; Milewicz
et al., 2000). On the other hand, many obesity syndromes are
also associated with low sympathetic activity (Bray and York,
1998). While the relationship between Arc NPY and the SNS
has been postulated, with demonstrations that hypothalamic
NPY administration reduces sympathetic firing rate (Lundberg
et al., 1989) or reduces sympathetically mediated processes
such as BAT thermogenesis (Egawa et al., 1991), there is little
known about the pathways involved or the underlying mecha-
nism that controls it.
BAT has gained interest as a possible target for the normal
control and treatment of obesity in adult humans via modulation
of cold-induced and adaptive thermogenesis (Stephens et al.,
2011). Moreover, there is an inverse correlation between the
amount of BAT and body mass index in humans, with obese
individuals having significantly less BAT than lean individuals
(Virtanen et al., 2009). Considering the critical role that Arc
NPY plays in the control of energy homeostasis, together with
the fact that pair-fed animals with elevated Arc NPY levels still
develop obesity (Sainsbury et al., 1997b; Zarjevski et al.,
1993), we aimed to determine the brain circuits via which Arc
NPY controls energy expenditure and SNS activity and subse-
quently modulates BAT activity. To this end, we utilized mouse
models in which NPY is only produced in the Arc ectopically
as well as more specifically only in Arc NPY neurons while it is
absent everywhere else. This was achieved by adeno-associ-
ated virus (AAV)-mediated neuronal expression of NPY specifi-
cally in the Arc of NPY knockout (NPY/) mice as well as
AAV-FLEX-NPY-mediated Arc-NPY-specific expression in
NPYCre knockin mice. NPY/ mice were used because they
enabled us to specifically dissect the role of Arc NPY indepen-
dently of effects of other central or peripheral NPY pathways.
Knowledge of the central regulation of BAT functionality gained
from these experiments using techniques that are impossible in
humans provides new information relevant to the control of
energy homeostasis in humans.
RESULTS
Long-Term High-Fat Feeding Induces Elevation of Arc
NPY mRNA Expression
Under normal conditions, Arc NPY expression is controlled by
peripheral factors such as leptin and insulin and satiety factors
like peptide YY (PYY), all of which reduce Arc NPY messenger
RNA (mRNA) levels thus signaling a positive energy balance
(Batterham et al., 2002; Elmquist et al., 1998; Marks et al.,
1990). On the other hand, fasting and ghrelin action promote
the opposite: an upregulation of Arc NPY mRNA levels, which
signal negative energy balance and trigger an increase in appe-
tite and a reduction in energy expenditure (Kamegai et al., 2000;
Sainsbury and Zhang, 2010). This was evident in the Arc of wild-
type (WT) mice after a 24 hr fasting period, which showed signif-Cell Micantly elevated NPY mRNA expression (Figure 1Aa), compared
to that in nonfasted chow-fed mice (Figure 1Ac). Paradoxically,
these principles no longer apply under conditions of long-term
overfeeding as seen in mice fed a high-fat diet for 20 weeks,
in which Arc NPY mRNA expression was also significantly
increased compared to chow-fed controls (Figures 1Ab and
1Ac). These results suggest that the dysregulated Arc NPY levels
present in the high-fat-fed animals mimic an energy-deficit state
that most likely exacerbates the already established obesity due
to a further increase in food intake and reduction in energy
expenditure, highlighting the critical importance of the Arc NPY
system under obese conditions.
Mouse Models for Specific Expression of NPY Only
in the Arc
In order to recapitulate the changes in energy expenditure under
conditions of energy-deficit or long-term high caloric intake, and
to specifically characterize the neuronal pathways involved in
Arc NPY-induced reduction in energy expenditure and thermo-
genesis, we generated mouse models in which NPY is either
overproduced in WT mice specifically in the Arc or selectively
reintroduced into the Arc of otherwise NPY-deficient mice. We
injected a recombinant adeno-associated virus that expresses
NPY under a neuron-specific promoter (AAV-NPY) into the Arc
of 11-week-old WT or germline NPY/ mice (hereafter referred
to as WT+NPY or ArcNPY, respectively) using an empty AAV
(AAV-empty) as a control (hereafter referred to as WT+empty
or NPY/+empty, respectively). Viral delivery was targeted to
just next to the Arc to avoid destruction of the nucleus, but close
enough to allow diffusion of the virus into the Arc (right side of
Figure 1Ba and higher-magnification of the boxed area in Fig-
ure 1Bb). The needle track shown in Figure 1Bb confirmed the
precise Arc-targeted injection. Immunohistochemistry revealed
a unilateral increase in NPY peptide expression in the Arc of
NPY/ mice (Figure 1Bb).
In addition to these models, we also utilized our NPYCre
knockin line, which allows NPY to be specifically expressed
only in NPY neurons in the Arc. In this model, the Cre-recombi-
nase gene is under the control of the endogenous NPY
promoter. When injected with an AAV-NPY-FLEX vector, this
guarantees that Cre-recombinase is only active in NPY neurons
and that inversion of the inactive NPY gene in the AAV-NPY-
FLEX vector to the active form only occurs in these NPY-ex-
pressing neurons. Successful activation of NPY expression in
the Arc through this method is shown in Figure 1Bc, with NPY
neurons indicated by the coexpression of mCherry (red) and
NPY derived from the viral vector visualized by immunohisto-
chemistry (green).
Consistent with previous results (Lin et al., 2006), vector-medi-
ated NPY expression was seen as early as day 3 after injection
and was stable for at least 6 months, at which time the expres-
sion was still confined to the Arc (data not shown). In keeping
with our histological confirmation of successful reintroduction
or overexpression of NPY in the Arc, body weight of our models
was markedly increased over the 8 weeks after the injection
period, as compared to their corresponding controls (Figure S1A
available online). Interestingly, however, body weight gain in
the Arc reintroduced models on an otherwise NPY-deficient
background was significantly less than that of WT miceetabolism 17, 236–248, February 5, 2013 ª2013 Elsevier Inc. 237
Figure 1. Arc NPY Expression under Various Conditions
(A) 35S-labeled in situ hybridization shows NPY mRNA expression in the Arc of WT mice fasted for 24 hr (a), (b) after 20 weeks of high-fat diet (HFD) (b), and
nonfasted chow-fed WT mice (c). The scale bar represents 60 mm.
(B) Shown in (a) is a photomicrograph of coronal brain section showing immunostaining of NPY after unilateral injection of AAV-NPY virus into the Arc of NPY/
mice (on the right side). Shown in (b) is a higher-magnification of boxed area in (a) showing the needle track just outside the Arc (the scale bar represents 40 mm).
Shown in (c) is a representative photomicrograph of coronal brain section showing successful NPY restoration only into NPY neurons of the Arc of NPYCre
knockin mice with an AAV-FLEX-NPY vector. The reintroduced NPY is detected with immunohistochemistry with an antibody coupled to a green fluorescence
protein seen as yellow due to the overlap of colocalized red fluorescence of the mCherry gene only expressed in NPY-expressing neurons. The scale bar
represents 40 mm. Inset is a higher magnification of the boxed area; the scale bar represents 25 mm. 3V, the third cerebral ventricle; Arc, arcuate nucleus.
(C) Daily food intakemeasured 1week after AAV virus injection. Data aremeans ± SEM. n = 8–10mice per group. *p < 0.05 versus genotype-matched AAV-empty
or for the comparisons indicated by horizontal bar.
See also Figure S1.
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of NPY are also critical for increasing body weight. Importantly,
there was no significant difference between the ArcNPY and
the Arc-FLEX-NPY groups with regard to body weight and other
parameters described below, suggesting the effects of NPY in
the ArcNPY model are mediated by NPY neurons. However,
since overexpression of NPY in WT, Y1/, Y2/, and Y1lox/lox
mice, all of which were used in this study, was not possible
with the AAV-FLEX-NPY virus, all comparisons below are shown
between WT+NPY or ArcNPY and the respective AAV-empty
controls.
Arc Only NPY Signaling Directly Decreases Whole-Body
Energy Expenditure
In order to investigate the direct consequences of Arc NPY
signaling on energy expenditure while avoiding potential
secondary effects that could be caused by themarked increases
in body weight that occur over a longer period of time (Fig-
ure S1A), we analyzedWT+NPY and ArcNPYmice within the first238 Cell Metabolism 17, 236–248, February 5, 2013 ª2013 Elsevier In3 weeks after viral delivery. Mice were monitored for body
weight, energy expenditure, and food intake. At day 8 after injec-
tion, NPY/+emptymice consumed significantly less food than
did theWT+empty mice (Figure 1C). Importantly, however, food
intake was increased overWT+empty values in theWT+NPY and
ArcNPY mice, with ArcNPY mice also consuming significantly
more than their corresponding controls, confirming the function-
ality of the virally delivered NPY (Figure 1C). Despite this increase
in 24 hr food intake, body weight (Figure S1B) and whole-body
fat mass (Figure S1C) were not significantly different from those
of mice in the WT+empty or NPY/+empty groups.
Strikingly, despite similar body weight and adiposity, oxygen
consumption (Figure 2A) and carbon dioxide (CO2) production
(Figure S1D) in WT+NPY and ArcNPY mice were reduced
compared to the corresponding control values (Figure 2A).
These changes were associated with a significant reduction in
energy expenditure in both genotypes (Figure 2B), indicating
a direct inhibitory action caused by Arc NPY signaling. These
findings strongly suggest that Arc NPY reduces energyc.
Figure 2. Effects of Arc NPY Signaling on Oxygen Consumption and Energy Expenditure in WT and NPY–/– Mice
Oxygen consumption (A) and energy expenditure (B) measured by indirect calorimetry 1 week after injection with AAV-empty or AAV-NPY vectors into the Arc of
13-week-old WT and NPY/mice, respectively. Open and black horizontal bars indicate light and dark phases, respectively. Average oxygen consumption and
energy expenditure over total 24 hr period were also calculated and are shown as bar graphs. Data are means ± SEM. n = 5–8 mice per group. *p < 0.05 and
**p < 0.01 versus genotype-matched AAV-empty controls or for the comparison indicated by horizontal bar. See also Figure S1.
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weight occur, implying that the direct inhibitory effect observed
is not simply a consequence of increased body weight or
adiposity.
While Arc NPY signaling had significant short-term effects on
oxygen consumption and energy expenditure, there was no
major effect of Arc NPY signaling on physical activity in WT or
NPY/ mice (Figure S1E). However, respiratory exchange ratio
(RER), an index of oxidative fuel source in NPY/+empty mice,
was significantly lower than that in WT+empty mice, with
ArcNPY mice showing a trend to reverse this effect on RER
(p = 0.1), which is particularly evident during the dark phase
(Figure S1F).
Taken together, these observations demonstrate that Arc
NPY signaling directly inhibits energy expenditure indepen-
dently of changes in body weight without major influences on
physical activity and show that Arc NPY might have a role in
fuel source selection, which could potentially impact on energy
expenditure. These differences in energy expenditure also point
to the possibility that the Arc-NPY-induced reduction in energy
expenditure may be associated with modulation of body
temperature. However, rectal temperatures of WT+NPY and
ArcNPY mice in the short-term experiment were not different
from those of genotype-matched control mice (data not
shown). More-sensitive measures of temperature were thus
conducted.
Arc Only NPY Signaling Decreases BAT Temperature
Since levels of NPY are strongly influenced by stress, we
utilized a noninvasive high-sensitivity infrared imaging camera
to monitor the temperature of interscapular BAT (TBAT), as
indicated by the temperature of the overlaying skin in com-
parison with body temperature represented by lumbar skin
temperature of freely moving animals (TBack). These experiments
were done 10 days after Arc NPY administration. There wasCell Mno difference in BAT temperature between WT+empty and
NPY/+empty mice (Figures 3A and 3B). However, WT+NPY
mice displayed a significant reduction in BAT temperature
compared to WT+empty control mice (Figures 3A and 3B).
Importantly, NPY reintroduction only into the Arc of NPY/
mice also led to a significant reduction in BAT temperature
relative to that of NPY/+empty mice (Figures 3A and 3B),
demonstrating that NPY signaling in this nucleus alone is able
to influence BAT thermogenesis. Lumbar temperature reflecting
overall body temperature showed a significant reduction in WT
mice upon Arc NPY overproduction but did not reach signifi-
cance in the NPY reintroduction models (Figure 3B), suggesting
that other NPY sources might contribute to this body tempera-
ture control.
Arc NPY Signaling Controls POMC and GAD65 but Not
AGRP Expression
Having demonstrated the clear link between Arc NPY and energy
expenditure and BAT thermogenesis, we next attempted to
dissect the neuronal pathways and circuits initiated by Arc-
specific NPY signaling. First, we assessed how increased Arc
NPY signaling affects the expression levels of other known regu-
lators of energy balance such as POMC and AGRP (Mountjoy,
2010; Ollmann et al., 1997; Tolle and Low, 2008) using in situ
hybridization. Unilateral injection of the respective AAV vectors
was chosen because it allowed us to use the contralateral side
as an internal control. As an additional control, different sets of
WT and knockout animals were unilaterally injected with an
empty vector (AAV-empty). NPY/+empty mice did not show
any significant difference from WT+empty mice with respect to
Arc mRNA expression levels of POMC (Figure 4A). However,
compared to the levels in genotype-matched AAV-empty-in-
jected controls, overexpression of NPY targeted to the Arc led
to marked reductions in POMC mRNA expression in WT+NPY
mice (64.5% ± 5.2% versus 100.0% ± 3.2% in WT+emptyetabolism 17, 236–248, February 5, 2013 ª2013 Elsevier Inc. 239
Figure 3. Effect of Arc NPY Signaling on
BAT Thermogenesis
(A) Color-coded infrared images visualizing BAT
temperatures (rectangular shape, Ar1) and body
temperatures (oval shape, El1) of WT and NPY/
mice injected with either AAV-empty or AAV-NPY
into the Arc. Automatically extracted hottest/
coldest pixels and average temperature of area of
interest are displayed at the top left hand corner of
the images. Representative images of 8–10 mice
per group.
(B) Average maximum temperature of BAT (TBAT)
and average maximum temperature of lumbar
back (Tback) of WT and NPY
/ mice injected with
either AAV-empty or AAV-NPY measured at week
2 after Arc injection. Data are means ± SEM. n = 8–
10 mice per group. *p < 0.05 versus genotype-
matched AAV-empty.
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ArcNPYmice (77.4% ± 8.7% versus 100.4% ± 6.0% in NPY/+
empty mice, means ± SEM of five mice per group, p < 0.01)
(Figure 4A).
It has been suggested that NPY in the hypothalamus may
modulate gamma aminobutyric acid (GABA)-ergic activity, and
through this pathway indirectly influence POMC expression
(Cowley et al., 2001; Horvath et al., 1992; Jegou et al., 1993; Ver-
goni and Bertolini, 2000). We thus investigated the effect of Arc
NPY signaling on mRNA expression of glutamic acid decarbox-
ylase 65 (GAD65), a key enzyme in the synthesis of GABA. Base-
line levels of GAD65 mRNA were not significantly different
between WT and NPY/ mice (Figure 4B). However, overpro-
duction or reintroduction of Arc-specific NPY expression re-
sulted in significant elevations in Arc GAD65 mRNA levels in
both WT and NPY/ mice (Figure 4B). This suggests that Arc
NPY may enhance GABA production by increasing Arc GAD65
production, which may subsequently contribute to the reduction
of POMCmRNA expression. Interestingly, the mRNA expression
levels of AGRP, which is coexpressed with endogenous NPY in
some Arc neurons and whose expression levels were no
different between WT and NPY/ mice at baseline, did not
change upon overproduction or re-introduction of NPY in WT
or NPY/ mice, respectively (Figure 4C). Thus, Arc NPY seems
not to be involved in the feedback control of AGRP, suggesting
that NPY and AGRP can influence energy homeostasis
independently.240 Cell Metabolism 17, 236–248, February 5, 2013 ª2013 Elsevier Inc.Arc NPY Controls Tyrosine
Hydroxylase Expression in the PVN
In order to determine other downstream
targets of Arc NPY signaling, we next
aimed to identify the chemical identity of
neurons activated by Arc-specific NPY.
Comparing the expression of mRNA
of various neurotransmitters in the PVN
of lean versus high-fat-diet-fed obese
animals, which are known to have
elevated Arc NPY levels (Figures 1Aa
and 1Ac), we identified tyrosine hydroxy-
lase (TH), the rate-limiting enzyme in thesynthesis of catecholamines, as a major candidate on account
of its significant downregulation in expression in response to
a high-fat diet (Figure 4D). To confirm these PVN TH neurons
as targets for Arc NPY signaling, we used our AAV-NPY expres-
sion system and overexpressed or reintroduced NPY unilaterally
into the Arc of WT and NPY/mice. As shown in Figure 4E and
quantified in Figure 4F, in both genotypes the elevated expres-
sion of NPY in the Arc caused a significant decrease in TH
mRNA expression in the PVN only on the injected side (at right
in the figure), but not on the contralateral noninjected control
side (left) or under conditions of empty virus injection. Impor-
tantly, another prominent nucleus of TH expression, the locus
coeruleus (LC), also showed significant downregulation of TH
mRNA only on the injected side (at right on the figure) and not
on the contralateral noninjected control side at left or in empty
virus-injected controls (Figures 4E and 4F). Interestingly, the
downregulation of TH mRNA in the two nuclei investigated
(PVN and LC) was not significantly different between Arc-
specific NPY-overexpressing WT and NPY/ mice (Figure 4F),
suggesting that extra-Arc NPY may not play a critical role in
the regulation of TH mRNA expression in the PVN or LC. Consis-
tent with the decreased mRNA level of TH in the PVN and LC of
Arc-specific NPY overexpressing mice, decreased TH protein
expression was also identified in these two nuclei by immunohis-
tochemistry (Figures 5A and 5B). In fact, in the PVN and LC of
ArcNPYmice, there were 61 ± 9 and 82 ± 8 TH-positive neurons,
respectively, in the injected side (at right in Figures 5A and 5B)
Figure 4. Arc NPY Induced Signaling and Neurotransmitter Regulation
(A) Emulsion-dipped autoradiographs of POMCmRNA expression in the Arc of WT and NPY/mice unilaterally injected (on the right side of the figure) with AAV-
empty vectors and AAV-NPY vectors. The scale bar represents 40 mm. Images are representative of five to six mice per group. Arc, acuate nucleus; 3V, the third
cerebral ventricle.
(B and C) Quantification of GAD65 and AGRP mRNA expression in the Arc, respectively, expressed as a percent of expression level of AAV-empty-injected WT
mice. Data are means ± SEM. n = 5–6 mice per group. *p < 0.05 versus genotype-matched AAV-empty controls.
(D) In situ hybridization of TH mRNA in the PVN of WT mice fed with a chow diet or with a high-fat diet for 20 weeks. The scale bar represents 40 mm. Images are
representative of n = 5.
(E) Emulsion autoradiographs of TH mRNA expression determined by in situ hybridization in the PVN or locus coeruleus (LC) of WT and NPY/mice unilaterally
injected (right side) with either AVV-empty or AAV-NPY into the Arc. The scale bar represents 60 mm. 3V, the third cerebral ventricle; 4V, the fourth cerebral
ventricle; PVN, paraventricular nuclei.
(F) Quantification of THmRNA expression in the PVN and LC expressed as a percent of expression level of AAV-empty-injectedWTmice. Data are means ± SEM.
n = 5–6 mice per group. *p < 0.05 versus genotype-matched AAV-empty controls.
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tively, on the contralateral noninjected control side (shown at
left). This set of results clearly identifies TH-positive neurons in
the PVN and LC as critical downstream targets of Arc NPY
signaling and potential mediators of the associated reduction
in energy expenditure.Cell MTH Expression in the PVN Is Controlled by Y1 Receptor
Signaling
Having established the role of Arc NPY signaling in the control of
TH expression in the PVN and LC, we next focused on identifying
the Y receptor(s) critical for mediating this action. To achieve
this, we initially used germline Y-receptor knockout modelsetabolism 17, 236–248, February 5, 2013 ª2013 Elsevier Inc. 241
Figure 5. Arc NPY Decreases TH Protein Expression through Y1 Receptor Signaling in TH Neurons of the PVN
(A and B) Immunohistochemistry of TH protein expression in the PVN (A; the scale bar represents 60 mm) and LC (B; scale bar = 100 mm) of NPY/mice 4 weeks
after unilateral injection (right side) of AVV-NPY into the Arc. (Ba) and (Bb) show the boxed areas in (B) at higher magnification (the scale bar represents 10 mm).
Images are representative of five mice per group. PVN, paraventricular hypothalamic nuclei; LC, locus coeruleus.
(C and D) Quantification of TH mRNA expression in the PVN and LC of WT, Y1/, and Y2/mice unilaterally injected into the Arc with AAV-empty or AAV-NPY
vectors. Data are means ± SEM. n = 5 mice per group. *p < 0.05 versus genotype-matched AAV-empty-injected control mice.
(E) Double labeling of in situ hybridization for Y1 mRNA and immunohistochemistry for TH expression in the PVN of WT mice. The scale bar represents 25 mm. A
higher magnification of the boxed area is shown in (Ea); the scale bar represents 5 mm. Black arrows indicate neurons positive only for TH and white arrows
neurons positive for both TH and Y1 receptors.
(F) Bright-field micrograph of reduced c-fos expression in unilateral deleted conditional Y1lox/lox mice (right side) followed by i.c.v delivery of [Leu31,Pro34] NPY
4 weeks later. The scale bar represents 40 mm.
(G) Emulsion-dipped autoradiographs of THmRNA expression in the PVN and the LC of unilaterally injected (right side) Y1lox/loxmicewith either AAV-empty vector
or AAV-Cre vector, followed by i.c.v. [Leu31,Pro34] NPY 4 weeks later. The scale bar represents 40 mm. Quantification of TH mRNA expression in the PVN and LC is
expressed as a percent of expression level of AAV-empty-injected Y1lox/lox control mice. 3V, the third cerebral ventricle; 4V, the fourth cerebral ventricle. Data are
means ± SEM. n = 4 mice per group. *p < 0.05 versus AAV-empty-injected control mice.
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with our AAV-NPY virus and using empty vector (AAV-
empty) injection as a control. Compared to AAV-empty-injected
WT and Y2/ mice, TH mRNA levels analyzed by in situ242 Cell Metabolism 17, 236–248, February 5, 2013 ª2013 Elsevier Inhybridization were significantly decreased in the PVN and
LC of AAV-NPY-injected WT and Y2/ mice (Figures 5C and
5D). By contrast, TH mRNA expression in the PVN and LC
of AAV-NPY-injected Y1/ mice did not differ from that ofc.
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results suggest that Y1 receptor signaling in TH neurons in the
PVN can be directly activated by NPY derived from the Arc,
mediating the inhibition of expression of TH mRNA.
To definitively prove that Y1 receptors in the PVN control TH
expression, and to establish the sequence of activation of
specific TH neuron populations in brain regions, we performed
immunohistochemistry for TH combinedwith in situ hybridization
for Y1 receptors. As shown in Figure 5E, a major proportion
(68% ± 11%) of TH-immunoreactive neurons in the PVN were
also positive for Y1 receptor expression, suggesting that activa-
tion of Y1 receptor signaling directly in these cells controls TH
expression. To prove this functionally, we next injected condi-
tional Y1 receptor knockout (Y1lox/lox) mice unilaterally into the
PVN with a Cre-recombinase-expressing AAV vector (AAV-Cre)
in order to induce unilateral Y1 receptor deletion in this nucleus.
Importantly, 4 weeks after Y1 receptor deletion, i.c.v. injection of
the Y1 receptor-preferring agonist [Leu31,Pro34]NPY showed a
significant reduction in c-fos activation only in the deleted site
of the PVN compared to the nondeleted contralateral side (Fig-
ure 5F, 54 ± 7 c-fos-expressing nuclei in the Y1-receptor-
deficient side at right in the figure versus 101 ± 12 in the control
side at left; data are means ± SEM of four mice per group, p =
0.005). Importantly, mice unilaterally depleted of Y1 receptors
in the PVN, when i.c.v. injected 4 weeks later with the Y1
receptor-preferring agonist [Leu31,Pro34]NPY, showed higher TH
mRNA expression in the Y1 receptor depleted side of the PVN
and LC (at right of each panel in Figure 5G) compared to the
noninjected contralateral side of each nucleus (at left). By
contrast, there was no difference between the injected and non-
injected sides of the PVN and LC in brains of mice injected
with the AAV-empty control vector (Figure 5G). The elevated
PVN and LC TH mRNA expression seen in the Y1-deficient
side of the brain also translated into an increase in TH protein
levels in the corresponding side of the PVN and LC (Figures 6A
and 6B). Importantly, this pattern of increased TH mRNA and
protein expression on the side of the unilateral Y1 depletion in
the PVN can also be seen in the nucleus of tractus solitarius
(NTS) and in the C1/A1 adrenergic or noradrenergic neurons
in the ventrolateral medulla (VLM) of the brainstem (Figure 6C),
suggesting that NPY signaling on Y1 receptors in the PVN
decreases catecholamine synthesis in this nucleus which subse-
quentially also triggers a reduction in TH production in the LC
and other brainstem areas, potentially leading to decreased
sympathetic outflow.
Arc NPY Signaling Controls UCP1 Expression in BAT
To further verify our hypothesis that increased Arc NPY-ergic
tone can influence SNS activity, we chose to investigate the
activity of BAT as it is known to be an intensely sympathetically
innervated peripheral target tissue (Lever et al., 1988). First, we
carried out bilateral surgical sympathetic denervation (Engel
et al., 1992) of BAT to confirm the critical input from these
neurons on this tissue and we measured the changes in protein
levels of uncoupling protein 1 (UCP1) in BAT as an indication of
changes in activity. While baseline protein levels of UCP1
were significantly increased in NPY/ compared to WT mice,
BAT denervation significantly reduced UCP1 levels in both geno-
types (Figure 7A), confirming sympathetic activity as a majorCell Mcontributor to UCP1 protein expression. In addition, we also
investigated the protein expression levels of peroxisome prolifer-
ator-activated receptor-g coactivator (PGC1a), a key transcrip-
tional regulator of UCP1 whose expression has been reported
to be increased in response to activation of the sympathetic
nervous system (Puigserver et al., 1998). Interestingly, PGC1a
protein levels were not different among sham-operated and
denervated groups ofWT andNPY/mice (Figure 7B), suggest-
ing little or no involvement of PGC1a in the Arc NPY induced
sympathetically mediated regulation of BAT UCP1 expression.
Similar to the denervation experiment shown in Figure 7A, lack
of NPY, as in NPY/+empty-injected mice, led to a strong
increase in the UCP1 mRNA (Figure 7C) and protein (Figure 7D)
expression in the BAT compared to corresponding values in
WT+empty mice, with quantification shown in Figure 7E. More
importantly, Arc injection of NPY in either WT or NPY/ mice
markedly and significantly reduces UCP1 mRNA and protein
expression in BAT (Figures 7C–7E). Indeed, there was a nearly
3-fold reduction in BAT UCP1 mRNA expression in ArcNPY rela-
tive toNPY/+emptymice, consistent with a direct effect of Arc
NPY signaling on BAT function. Furthermore, we also investi-
gated the expression of PGC1a in BAT in response to Arc NPY
signaling. Similar to the denervation experiments, there was no
significant difference in PGC1a protein level in theArcNPY group
compared to the other three groups (Figure 7D, quantified in Fig-
ure 7F), albeit there was a trend to a reduction in PGC1a protein
expression in ArcNPY mice compared to NPY/+empty
controls (p = 0.07), suggesting that reduction of UCP1 expres-
sion induced by elevated Arc NPY is not necessarily mediated
by action of PGC1a in BAT.
To further validate our hypothesis that the alterations of BAT
activity were influenced by NPY signaling via Y1 receptors, we
also injected germline Y1/ mice with AAV-empty (Y1/+
empty) or AAV-NPY (Y1/+NPY) into the Arc and investigated
the expression of UCP1 and PGC1a in BAT. At baseline, mice
lacking the Y1 receptor, as in Y1/+empty mice, exhibited up-
regulated UCP1 protein levels compared to WT+empty mice
(Figure 7E). In contrast to the marked reduction in BAT UCP1
protein expression seen in WT+NPY and ArcNPY mice, Y1/+
NPY mice showed no such decreases relative to Y1/+empty
mice (Figure 7E), and there was also no difference in the levels
of PGC1a either (Figure 7E). These findings, together with our
discovery of the effect of Y1 receptor deletion in the PVN on
TH expression (Figures 5A and 5C), confirms that Y1 receptors
in the brain, particularly in the PVN, are critical for the inhibitory
action of Arc NPY on UCP1 expression in BAT.
DISCUSSION
This study demonstrates that Arc NPY-induced signaling is crit-
ical for the control of the hypothalamic and brainstem TH
systems that modulate sympathetic outflow, and subsequently
energy expenditure including BAT thermogenesis. Results
generated by our Arc-only NPY expression models suggest
that while Arc NPY has an important role in stimulating feeding,
most likely involving alterations in GAD65 and POMC activities
in the hypothalamus, which will lead to obesity over time,
the control of food intake is not the only critical function of
Arc NPY. Indeed, we found that Arc-derived NPY could directlyetabolism 17, 236–248, February 5, 2013 ª2013 Elsevier Inc. 243
Figure 6. Y1 Receptors Signaling Controls TH Protein Levels in the PVN, LC, NTS, and A1/C1 Neurons
Immunohistochemistry of TH protein expression in the PVN (A), the LC (B), and the NTS (C) and A1/C1 region of Y1lox/lox mice unilaterally injected with AAV-Cre
(right side) followed by i.c.v injection of 1.5 ml [Leu31,Pro34] NPY 4weeks later. The scale bar represents 100 mm. Subpanels show higher magnifications of the boxed
areas; scale bars represent 40 mm. Images are representative of five mice. PVN, paraventricular nucleus; LC, locus coeruleus; NTS, nucleus of tractus solitarius;
C1/A1, adrenaline neurons/noradrenaline neurons; 3V, the third cerebral ventricle; 4V, the fourth cerebral ventricle; Cc, central canal.
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NPY and Energy Expenditurecontrol whole body energy homeostasis, as evidenced by a rapid
and robust reduction in energy expenditure in ArcNPY mice
well before body weight and adiposity were significantly
increased. The central mechanism behind this direct control of
energy expenditure initiated by Arc NPY is likely due to
decreased sympathetic nervous system activity, as shown by
decreased TH mRNA and protein expression in the PVN, LC,
and brainstem. Importantly, we identified Y1 receptors colocal-
ized on TH neurons in the PVN as the relay point, making it
unlikely that Arc NPY directly influences TH levels in the LC
and other regions in the brainstem. Consistent with a significant244 Cell Metabolism 17, 236–248, February 5, 2013 ª2013 Elsevier Indecrease in activity of TH-expressing neurons in the brain, we
also demonstrated that this Arc-specific alteration of NPY
signaling led to a significant temperature reduction in BAT in
association with a downregulation of BAT UCP1 expression,
which could be reversed after surgical sympathetic denervation
to BAT. Therefore, these data show a causal relationship
between Arc NPY signaling and the sympathetic nervous system
activity. The potential pathways, neurotransmitters and mecha-
nisms by which Arc NPY signaling may influence food intake,
BAT thermogenesis and energy expenditure are summarized in
Figure S2.c.
Figure 7. Effects of Arc NPY Signaling on BAT UCP1 and PGC1a Expression
(A and B) Protein levels of UCP1 (A) and PGC1a (B) 3 weeks after bilateral sympathectomy of BAT of WT and NPY/ mice. The sham-operated genotype-
matched mice were used as controls. Data are means ± SEM. n = 5–7 mice per group. *p < 0.05, **p < 0.01 versus genotype-matched controls or for the
comparison indicated by horizontal bar.
(C) UCP1mRNA expression levels in the BAT ofWT or NPY/mice 3 weeks after being injected into the Arc with either AAV-empty or AAV-NPY. The values were
expressed as a percent of expression level of WT+empty mice.
(D) UCP1 and PGC1a protein levels in the BAT of WT or NPY/mice 3 weeks after being injected into the Arc with either AAV-empty or AAV-NPY determined by
western blot. Images are representative of four to five mice per group. GAPDH is used as a loading control.
(E and F) quantification of UCP1 and PGC1a protein expression in the BAT 3 weeks after Arc injection of AAV-empty or AAV-NPY vectors into of WT, NPY/, and
Y1/mice, respectively. Data aremeans ± SEM. n = 5–7mice per group. *p < 0.05, **p < 0.01 versus genotype-matched controls or for the comparison indicated
by horizontal bar.
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energy deficiencies, and this is associated with the promotion
of food consumption and conservation of energy. However,
under the condition of oversupplied nutrition in high-caloric-
diet-fed rodents or humans, elevated rather than decreased
NPY levels mislead the brain and worsen the symptoms of the
metabolic syndrome. In addition, elevation of Arc NPY expres-
sion during weight loss after energy restriction may be a strong
factor in preventing further weight loss. In this study, experi-
mental elevation of NPY in the Arc mimics these different condi-
tions, allowing us to dissect the downstream neuronal circuits
controlled by this altered Arc NPY signaling. Although Arc NPY
neurons project to several regions in the brain, the projection
to PVN TH-expressing neurons seems to be the most important
one for reducing sympathetic activity and thereby modulating
energy expenditure. Interestingly, our findings on Arc NPY
control of sympathetic output is consistent with a recent report
that chemical stimulation of the Arc in rats altered cardiovascular
responses by modulating sympathetic nerve activity in the PVN
(Kawabe et al., 2012).
Our data show that the phenotypes related to BAT function in
WT+NPY and ArcNPY mice are very similar, suggesting that
extra-Arc NPYmay not be critical in altering sympathetic outflow
relevant to BAT activity. However, potential actions of extra-Arc
NPY, either in the brain or in the periphery, cannot be completely
ruled out. Indeed, a recent study in rats showed that virus-medi-
ated overexpression of NPY in the DMH leads to body weight
gain associated with hyperphagia (Yang et al., 2009). Further-
more, it was also shown that knockdown of NPY in the DMH ofCell Mrats promotes the development of brown adipocytes in typical
WAT depots through sympathetic actions, and this increases
BAT activity and therefore enhances energy expenditure and
cold-induced thermogenesis (Chao et al., 2011). However, this
could be a rat-specific mechanism, since NPY expression in
the DMH of mice under normal conditions is rather low. In addi-
tion to the DMH, it has been shown that NPY can directly inhibit
neurons in the ventromedial nucleus (VMH), a crucial brain region
that suppresses food intake (King, 2006). It is also possible that
the lack of intact feedback circuits within the brain or from
peripheral tissues contributes to the differences in metabolic
effects of Arc NPY seen in WT and otherwise NPY-deficient
mice. In particular, the observed difference in body weight
between WT and NPY/ mice after chronic overproduction of
NPY in the Arc highlights the importance of the entire NPY
system for achieving overall control of energy homeostasis.
The identification of TH-expressing neurons in the PVN, a crit-
ical brain region for the integration of neuroendocrine and auto-
nomic signals (Swanson and Sawchenko, 1980), as a major
target of Arc NPY action is a vital clue for understanding the
complex network of neurons regulating energy homeostasis.
Our data clearly demonstrate that Y1 receptor signaling in
TH-expressing neurons in the PVN suppresses the expression
of TH, and through this the activity of indices of sympathetic
nervous activity such as BAT temperature and BAT UCP1
expression. Located in the lateral parvocellular subregions of
the PVN, TH neurons are known to project to brainstem and
spinal cord autonomic regulatory centers and to integrate sym-
pathetic/parasympathetic outflow (Swanson and Sawchenko,etabolism 17, 236–248, February 5, 2013 ª2013 Elsevier Inc. 245
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NPY and Energy Expenditure1983). Furthermore, PVN anterograde tracing studies have
demonstrated that the LC is a primary target of neuronal projec-
tions from the PVN (Reyes et al., 2005; Zheng et al., 1995). As the
rate-limiting enzyme in the biosynthesis of the catecholamines
dopamine, noradrenaline, and adrenaline, TH forms the primary
control mechanism for the production of catecholamines. While
PVN TH-positive neurons are most likely dopaminergic, the LC
consists of a compact population of TH-positive neurons that
are exclusively noradrenergic, readily identifiable by their ex-
pression of catecholamine-synthetic enzymes (Geerling et al.,
2010). In addition, LC noradrenergic neurons project to a variety
of other areas of the brain, including the hypothalamus, amyg-
dala, hippocampus, and striatum, where they are involved in
regulating stress responses and stress-related vigilance and
arousal, not uncommon conditions associated with elevated
Arc NPY levels mimicking negative energy balance. Importantly,
it has also been shown that TH-positive neurons in the PVN
directly project to brainstem autonomic regions such as the
NTS and A1/C1 cell groups (Geerling et al., 2010). From there,
the catecholamine-synthesizing neurons in the brainstem send
efferent signals to the spinal cord and control many autonomic
organs, including BAT, to regulate SNS-mediated thermogene-
sis and peripheral tissue metabolism.
Taken together, our data have demonstrated that increased
NPY expression in the Arc as commonly seen under fasting,
stress, or chronic-overfeeding conditions, acting via PVN Y1
receptors, results in a functional inhibition of TH tonus and BAT
thermogenesis. Our results also show the inhibitory function of
Arc NPY signaling in controlling POMC neurons, probably via
altering GAD65 levels, and this likely contributes to increased
food intake. Importantly, there was no change in AGRP expres-
sion upon Arc NPY administration, suggesting that there is no
feedback regulation by NPY on AGRP neurons. This also
suggests that AGRP, which is colocalized in some Arc NPY
neurons, can act independently of NPY, allowing different
components of energy homeostasis to be controlled by the
same neurons. This new discovery of the pathways modifying
neural sympathetic activity in response to Arc NPY provides
greater insights into the hypothalamic regulation of energy
homeostasis.EXPERIMENTAL PROCEDURES
Animals
All animal experiments were conducted in accordancewith relevant guidelines
and regulations. Male (wild-type, NPY/, Y1/, Y2/, conditional Y1
knockout Y1lox/lox, and NPYCre knockin) mice all on a mixed C57Bl6/129SVJ
background were used for these experiments. They were housed under condi-
tions of controlled temperature (22C) with a 12:12 hr light-dark cycle (lights on
at 07:00 hr) and fed a standard chow diet with ad libitum access to water,
except where noted. Generation of the NPY/, Y1/, Y2/, and conditional
Y1lox/lox mice has been described previously (Howell et al., 2003; Karl et al.,
2008; Sainsbury et al., 2002; Zhang et al., 2010). NPYCre knockin mice were
generated as described in the Supplemental Experimental Procedures.
Viral Vector Injection and Measurement of Body Weight and Fat
Mass
Hypothalamic Arc-targeted viral injection was performed as described in the
Supplemental Experimental Procedures. The physiological efficacy of viral
NPY expression was confirmed by the resultant increase in food intake.
Body weight was monitored twice a week at the same time of the day for246 Cell Metabolism 17, 236–248, February 5, 2013 ª2013 Elsevier In3 weeks in the short-term experiment and weekly for the 8 week experiment.
Whole-body fat was measured at 13 weeks of age with dedicated dual-energy
X-ray absorptiometry (DEXA; Lunar PIXImus2 mouse densitometer, GE
Medical Systems, Madison, WI) as described previously (Shi et al., 2011).
Indirect Calorimetry Studies, Food Intake, and Physical Activity
Oxygen consumption rate (VO2) and carbon dioxide output (VCO2) were
measured 1 week after AAV injection with an indirect calorimeter (Oxymax
series; Columbus Instruments, Columbus, OH) as described previously (Shi
et al., 2011). In brief, after 24 hr of acclimatization, VO2, VCO2, body weight,
and daily food intake were measured over a 24 hr period, and the RER and
energy expenditure were calculated. Relative physical activity of individually
housed mice was also evaluated.
BAT Temperature Measurements with Infrared Imaging
Temperature of interscapular BAT (TBAT) and body temperature wasmeasured
by noninvasive high-sensitivity infrared camera (ThermoCAM T640, FLIR) as
described in the Supplemental Experimental Procedures. Data were analyzed
with the ThermaCAM 7 Pro software calculating the hottest pixel and average
temperature of each area of interest.
Intrascapular BAT Bilateral Sympathectomy
Afferent sympathectomy of BAT was carried out in a subset of 11- to 12-week-
old male mice immediately after they had been injected with AAV-empty or
AAV-NPY virus as described in previously (Engel et al., 1992; Niijima et al.,
1984). In brief, with a microscope, intrascapular BAT was exposed by cutting
of the overlaying skin and the adjacent muscles. Five sympathetic nerve
bundles supplying each lobe of BAT were identified, carefully lifted with
forceps, and severed. A similar procedure was performed in sham-operated
groups except without sympathetic nerve incision of BAT. The mice were
placed on heat pads during surgery and until recovery.
RNA Extraction and Quantitative Real-Time PCR
BAT were dissected and immediately frozen in liquid N2, and total RNA was
isolated with Trizol Reagent and processed for quantitative real-time PCR
with the LightCycler system as described in the Supplemental Experimental
Procedures.
Western Blotting
BAT samples from all groups were homogenized in RIPA buffer as previously
described (Shi et al., 2011), and 20 mg protein was resolved by SDS-PAGE and
immunoblotted with antibodies against UCP1 (Alpha Diagnostic International,
San Antonio, TX), PGC1a (Calbiochem,Merck, Kilsyth, Australia), andGAPDH.
Immunolabelled bands were quantified by densitometry.
In Situ Hybridization
Coronal brain sections (20 mm) were cut on a cryostat and mounted on slides.
Matching sections from the same coronal brain level from the four groups of
mice (n = 5 mice/group) were assayed together using radiolabelled DNA oligo-
nucleotides complementary to mouse POMC, GAD65, AGRP, NPY, and TH.
Sequence of probes and details of the in situ hybridization methodology can
be found in the Supplemental Experimental Procedures.
Immunohistochemistry for Determination of NPY-Induced Changes
in the Brain
The mice were anaesthetized and the brains were perfused with saline and
then 4% paraformaldehyde (PFA). Brains were postfixed in 4% PFA and
then placed in 30% sucrose overnight and cut at 30 mm, and immunohisto-
chemistry was performed as described in the Supplemental Experimental
Procedures. After coverslipping, 12 sections from eachmouse were visualized
and counted for c-fos or TH immunoreactivity within the brain nuclei of interest
with a Zeiss Axioplan light microscope.
Double Immunostaining and In Situ Hybridization
Five WT male mice were killed and brains were immediately removed and
frozen. Coronal brain sections, 20 mm thick, were cut and mounted on slides.
Double immunostaining assays were carried out as described in details in the
Supplemental Experimental Procedures.c.
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All values are presented as means ± SEM. One- or two-way ANOVA (for body
weight, basal food intake, VO2, VCO2, energy expenditure, physical activity,
and RER) or repeated-measures ANOVA (BAT and lumbar temperature) was
used (GraphPad Prism 5, GraphPad Software). Bonferroni post hoc tests
were performed to identify differences amongmeans. p < 0.05 was considered
significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and two figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cmet.2013.01.006.
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